欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号IE/V/0648/001
药品名称Suiseng Coli /C
活性成分
    • clostridium perfringens Type C Toxoid 35.0 %
剂型Suspension for injection
上市许可持有人Laboratorios Hipra S.A. Avda. La Selva 135 17170 - Amer (Girona) Spain
参考成员国 - 产品名称Ireland (IE)
Suiseng
互认成员国 - 产品名称
    • Denmark (DK)
    • Belgium (BE)
      Suiseng Coli / C
    • Netherlands (NL)
    • Iceland (IS)
      Coliseng C
    • United Kingdom (Northern Ireland) (XI)
    • Austria (AT)
      Suiseng Coli / C Injektionssuspension für Schweine
    • France (FR)
    • Luxembourg (LU)
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
    • Sweden (SE)
    • Finland (FI)
    • Poland (PL)
    • Latvia (LV)
      Suiseng Coli / C suspensija injekcijām cūkām
    • Lithuania (LT)
      Suiseng Coli/C, injekcinė suspensija kiaulėms
    • Estonia (EE)
      Suiseng Coli/C
    • Liechtenstein (LI)
    • Hungary (HU)
    • Bulgaria (BG)
    • Cyprus (CY)
    • Czechia (CZ)
      Suiseng Coli / C injekční suspenze pro prasata
    • Romania (RO)
    • Slovakia (SK)
    • Slovenia (SI)
    • Croatia (HR)
    • Norway (NO)
    • Malta (MT)
    • Germany (DE)
许可日期2020/03/04
最近更新日期2024/05/14
药物ATC编码
    • QI09AB08 escherichia + clostridium
申请类型
  • TypeLevel1:food
  • TypeLevel2:Immunological
  • TypeLevel3:Full dossier - art 12.3 Dir 2001/82/EC
  • TypeLevel4:[not specified]
  • TypeLevel5:[not specified]
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase